#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

Thesis: The role of uveal melanoma-derived exosomes and signaling pathways in liver metastasis

The role of uveal melanoma-derived exosomes and signaling pathways in liver metastasis Raquel Ramos Martín Directed by…

Read More

#IDIBELLseminars: e-health interventions in Mental Health

FRIDAY 15.12 | 13:00 |  Sala Pau Viladiu  Hosted by Fernando Fernández-Aranda – Psychoneurobiology of Eating and…

Read More

De cultivar cèl·lules mare a fabricar humans al laboratori: present o futur?

Cafès científics UB 2023 La generació de models d’embrions humans a partir de cèl·lules mare ha impactat…

Read More

Taula debat: Not feeling at home in your own body: The role of socio-cultural influences and the rise of eating disorders in adolescents and young adults

Read More

Development and cancer: regulatory elements in pancreatic cancer onset

Gene alterations play a prominent role in driving cancer initiation and progression. Yet, mutations on oncogenes (those…

Read More

#IDIBELLfellows: Rana El Bizri

Modelling castration resistance in GEM models identifies histone methyltransferase Nsd2 as a target of AR sensitivity Rana…

Read More

#IDIBELLseminars: Fibrosis and inflammation in the lung – a reinforcing loop?

Pulmonary fibrosis includes more than 200 different lung diseases. Characteristic of pulmonary fibrosis are more or less…

Read More

#IDIBELLseminars: Gut microbiome disturbance and mucosal barrier dysfunction in gastrointestinal cancer development

Microbiome disturbance (reduced diversity, increased growth/activity of pathogenic species) and metabolic action associated with gut barrier dysfunction…

Read More

Incorporating genetic risk evaluation after diagnosis of cancer: From promise to practice

Presentació del dr Steven Katz, professor de la Universitat de Michigan del Departament Medicine and health Management…

Read More

#IDIBELLfellows: Karine Tadevosyan & Laura Granés

Heart-on-Chip as a biomimetic platform for cardiac physiology and drug toxicity testing Karine Tadevosyan Stem Cell Potency…

Read More
Scroll to Top